HiberGene Diagnostics

About:

HiberGene Diagnostics develops, manufactures and markets molecular diagnostic tests for human infectious diseases.

Website: http://www.hibergene.com/

Twitter/X: HiberGene

Top Investors: Medcaptain, EASME - EU Executive Agency for SMEs, Cantor Fitzgerald, Kernel Capital, Michael Bristow

Description:

Hibergene Diagnostics is a Dublin-based, private Irish company, that develops, manufactures and markets molecular diagnostic tests for human infectious diseases, using the LAMP (Loop Mediated Isothermal Amplification) technology. The company has a growing portfolio of tests, with tests for Meningococcus and Group B Streptococcus already available. In addition, Hibergene has an active research pipeline from which the company expects to release a number of tests on a yearly basis. The tests meet a significant unmet clinical need allowing clinicians to rapidly, accurately and easily detect human infectious diseases in a near patient setting. The company CEO is Brendan Farrell, an industry veteran, who was a founder of Trinity Biotech. The company is headquartered in Ireland and its investors include a number of institutions and private investors.